Filing Flows › Novartis AG (NVS) › Net income
Novartis AG (NVS) net income by quarter
Novartis AG's net income was $1.2B in Q3 2026 (third quarter 2026), -63% from Q2 2026. Over the last 6 quarters it ranged from $1.2B (Q3 2026) to $4.0B (Q2 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.2B | -63% | -70% |
| Q2 2026 | $3.2B | +3% | -20% |
| Q1 2026 | $3.2B | +31% | — |
| Q4 2025 | $2.4B | -39% | — |
| Q3 2025 | $3.9B | -3% | — |
| Q2 2025 | $4.0B | — | — |
Q3 2026 at a glance
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novartis AG's net income?
Novartis AG's net income was $1.2B in Q3 2026 (third quarter 2026), -63% from Q2 2026.
How has Novartis AG's net income changed?
Over the last 6 quarters it ranged from $1.2B (Q3 2026) to $4.0B (Q2 2025).